Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E. Capoluongo
Institution:
University of Naples Federico II
Observed institutions:
Azienda Ospedaliera San Giovanni Addolorata,
University of Naples Federico II
ORCID:
0000-0001-9872-0572
Observed ORCID:
0000-0001-9872-0572
OpenAlex ID:
A5077088902
LBA7 The Rome trial from histology to target: The road to personalize targeted therapy and immunotherapy
2024
·
A. Botticelli
, S. Scagnoli
, et al.
·
Annals of Oncology
·
25
70MO Genomic profiling to expand precision cancer medicine in the real world: The ROME trial
2023
·
A. Botticelli
, S. Scagnoli
, et al.
·
ESMO Open
·
4
PDF
14P Comprehensive genomic profiling to guide personalized targeted and immunotherapy in gastrointestinal tumors: Subgroup analysis of the ROME trial
2025
·
C. Cremolini
, A. Botticelli
, et al.
·
Annals of Oncology
·
1
95O Atezolizumab plus ipatasertib shows promise in extending survival for patients with PI3K/AKT/PTEN-altered advanced solid tumors: An exploratory analysis of the ROME trial
2025
·
A. Botticelli
, S. Lonardi
, et al.
·
ESMO Open
Show more works
View as search
Works count:
4
Citation count:
30
H-index:
2
I10-index:
1
Year
Topic
Type